United States · 
What does Rho Capital Partners invest in?
Rho Capital Partners invests most often at Series B and Series A (44% of the rounds on record), in sectors such as Telehealth, Health-tech and Batteries.
Rho Capital Partners highlights
- 01
1 cheques in the last 12 months
- 02
Mostly Series B and Series A: 44% of its rounds
- 03
Sole investor in 5 rounds, median $4.0M
- 04
24 exits from the portfolio
What they do
Since 1981, Rho has been investing in innovation at all stages of growth.From their own website
- Type
- Private equity (from a list, unverified)
- Cheque size
- Not stated
- Stages
- SeedSeries ASeries BGrowthPre-IPO
- Sectors
- TelehealthHealth-techBatteries
- Based in
- New York, United States
- Cold pitches
- Not stated
The record
Every round we can evidence, newest first158 appearances
- 2026
1 round
- Apr
- 2019
3 rounds
- Dec
- Sept
- May
- 2018
2 rounds
- May
- May
- 2017
1 round
- Mar
- 2016
1 round
- Apr
- 2015
3 rounds
- Jun
- Jun
- Jan
- 2014
9 rounds
- Oct
- Jul
- Jun
- May
- May
- Apr
- Mar
- Mar
- Jan
- 2013
5 rounds
- Oct
- Jun
- May
- Apr
- Jan
- 2012
8 rounds
- Dec
- Nov
- Sept
- Aug
- Jul
- Jul
- May
- Jan
- 2011
19 rounds
- Nov
- Sept
- Sept
- Jul
- Jul
- Jul
- Jul
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
Named by the firm itself, on a filing, its Form ADV or its company registration5 named
HBHabib Benoit KairouzManaging Partner, Director, ShareholderiForm ADV
JRJoshua RuchCEO, Managing Partner, Director, ShareholderiForm ADV
MLMark LeschlyManaging Partner, Director, ShareholderiForm ADV
PKPeter KalkanisChief Financial Officer and Chief Compliance OfficeriForm ADV
WFWilliam F IndoeDirector, ShareholderiForm ADV
We also hold 11 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What the register says
From the firm's own filings with the SEC, which it must file accurately by law
$530Mgross assets of its fundsOct 2026
Exemptreporting adviserventure or small private funds
- Legal name
- RHO Capital Partners, INC
- SEC number
- CRD 160655
What they claim to have backed
From their own portfolio page (on their website)
14 of 25 we have independently watched raise
Abstractive HealthAlunaAugustAuvikCIQChargePointClearCloudpayConvercentCyleraDashlaneEveryday HealthFevoHumaACALVIOActive PowerAnacorBackbaseCapstoneCaraCienaDendreonDraivnFableticsGloucester Pharmaceuticals
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.
Exits from the portfolio
Companies it backed that were later bought or listed24 in all
SolarBridge TechnologiesBought by SunPower CorporationUndisclosedNov 2014
NuventixBought by Aavid ThermalloyUndisclosedJul 2014
FixmoBought by Good TechnologyUndisclosedJun 2014
PrecisionDemandBought by AOLUndisclosedMay 2014
Xora, Inc.Bought by ClickSoftware Technologies$15MFeb 2014
AdaptiveBlueBought by i.TVUndisclosedNov 2013
SARcode BioscienceBought by Shire$160MMar 2013
BroadLogic Network TechnologiesBought by BroadcomUndisclosedJan 2013
OMGPOPBought by Zynga$210MMar 2012
InnerWirelessBought by Black Box Network ServicesUndisclosedFeb 2012
XGraphBought by AddThisUndisclosedNov 2011
Anacor PharmaceuticalListedUndisclosedDec 2010
ReachLocalListedUndisclosedMay 2010
Gloucester PharmaceuticalsBought by Celgene$640MDec 2009
NowPublicBought by Examiner.comUndisclosedSept 2009
GearworksBought by Xora, Inc.UndisclosedAug 2009
Multispectral ImagingBought by AgiltronUndisclosedMay 2008
The latest 20 here. An exit counts when it came after the firm's first round in the company. From historical deal records.